HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ting-Tsung Chang Selected Research

adefovir dipivoxil (Hepsera)

4/2011Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents.
1/2011Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.
5/2009HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during adefovir dipivoxil therapy.
11/2008Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants.
9/2008Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.
12/2006Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.
6/2005Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
2/2003Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.
2/2003Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ting-Tsung Chang Research Topics

Disease

42Chronic Hepatitis B
04/2022 - 02/2003
26Infections
04/2022 - 04/2002
21Hepatocellular Carcinoma (Hepatoma)
01/2022 - 04/2002
17Fibrosis (Cirrhosis)
10/2021 - 12/2006
15Chronic Hepatitis C
03/2021 - 03/2003
14Neoplasms (Cancer)
08/2021 - 07/2002
10Liver Diseases (Liver Disease)
10/2021 - 04/2002
6Hepatitis B
04/2022 - 06/2002
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2019 - 08/2013
4Viremia
04/2022 - 03/2003
3Coinfection
04/2022 - 07/2007
3Cholangiocarcinoma
01/2020 - 11/2018
3Disease Progression
01/2019 - 01/2008
3Inflammation (Inflammations)
01/2019 - 01/2017
3Hepatitis
11/2014 - 01/2011
3Type 2 Diabetes Mellitus (MODY)
04/2012 - 12/2003
2Thrombosis (Thrombus)
07/2021 - 05/2019
2Neoplasm Metastasis (Metastasis)
07/2021 - 11/2018
2Fatty Liver
11/2019 - 01/2014
2Liver Neoplasms (Liver Cancer)
05/2019 - 05/2005
2Carcinogenesis
11/2018 - 01/2012
2Hepatitis C
01/2016 - 08/2013
2Virus Diseases (Viral Diseases)
11/2014 - 06/2008
2Autoimmune Diseases (Autoimmune Disease)
11/2014 - 04/2004
1Jaundice (Icterus)
12/2021
1Sepsis (Septicemia)
12/2021
1Acute Liver Failure (Fulminant Hepatic Failure)
12/2021
1Brain Diseases (Brain Disorder)
12/2021
1Ascites
12/2021
1Cicatrix (Scar)
11/2021
1Chronic Renal Insufficiency
11/2021
1Insulin Resistance
11/2019
1Prediabetic State (Prediabetes)
11/2019
1Carcinoma (Carcinomatosis)
01/2019
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2019

Drug/Important Bio-Agent (IBA)

27Hepatitis B e AntigensIBA
01/2020 - 02/2003
19entecavirFDA Link
11/2019 - 10/2005
18DNA (Deoxyribonucleic Acid)IBA
04/2022 - 02/2003
18Antiviral Agents (Antivirals)IBA
12/2021 - 02/2003
15Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2022 - 04/2002
14Alanine Transaminase (SGPT)IBA
12/2021 - 04/2002
11InterferonsIBA
01/2021 - 07/2005
11Ribavirin (Virazole)FDA LinkGeneric
12/2017 - 03/2003
9NucleosidesIBA
01/2014 - 03/2006
9Lamivudine (Epivir)FDA Link
05/2012 - 11/2004
9adefovir dipivoxil (Hepsera)FDA Link
04/2011 - 02/2003
6Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2011
6Immunoglobulin G (IgG)IBA
01/2019 - 11/2014
6NucleotidesIBA
10/2017 - 02/2003
4Pharmaceutical PreparationsIBA
11/2021 - 04/2004
4Interferon-alpha (Interferon Alfa)IBA
07/2016 - 03/2003
3RNA (Ribonucleic Acid)IBA
04/2022 - 11/2014
3asunaprevirIBA
12/2017 - 11/2014
3daclatasvirIBA
12/2017 - 11/2014
3Serum AlbuminIBA
05/2005 - 10/2004
2pgRNAIBA
04/2022 - 05/2021
2AntigensIBA
04/2022 - 06/2002
2BilirubinIBA
12/2021 - 05/2016
2Tyrosine Kinase InhibitorsIBA
07/2021 - 01/2020
2Immune Checkpoint InhibitorsIBA
07/2021 - 01/2020
2sofosbuvir drug combination ledipasvirIBA
03/2021 - 07/2016
2ProteomeIBA
01/2020 - 01/2019
2Apolipoprotein C-IIIIBA
01/2019 - 08/2013
2Polysaccharides (Glycans)IBA
01/2019 - 01/2019
2CytokinesIBA
01/2019 - 11/2014
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
03/2018 - 07/2002
2SofosbuvirIBA
01/2018 - 01/2016
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2017 - 08/2013
2Phosphotransferases (Kinase)IBA
08/2016 - 01/2012
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2016 - 01/2016
2Emtricitabine (Emtriva)FDA Link
05/2014 - 01/2011
2EnzymesIBA
08/2013 - 12/2006
2hydrogen sulfite (bisulfite)IBA
01/2012 - 01/2011
1Alkaline PhosphataseIBA
12/2021
1HLA-B Antigens (HLA-B)IBA
11/2021
1Carbamazepine (Tegretol)FDA LinkGeneric
11/2021
1Allopurinol (Remid)FDA LinkGeneric
11/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2021
1Cell-Free Nucleic AcidsIBA
08/2021
1Fetal Proteins (Fetoprotein)IBA
05/2019
1Sorafenib (BAY 43-9006)FDA Link
05/2019
1TelbivudineFDA Link
01/2019
1Complement C3 (C3 Complement)IBA
01/2019
1Blood Proteins (Serum Proteins)IBA
01/2019
1Glycoproteins (Glycoprotein)IBA
01/2019
1Inositol Polyphosphate 5-PhosphatasesIBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1AcetylglucosamineIBA
01/2019
1Capsules (Microcapsules)IBA
03/2018
1Estrogen ReceptorsIBA
03/2018
1Progesterone Receptors (Progesterone Receptor)IBA
03/2018
1ledipasvirIBA
01/2018
18- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
12/2017
1LipidsIBA
01/2017
1Nonesterified Fatty Acids (NEFA)IBA
01/2017

Therapy/Procedure

26Therapeutics
12/2021 - 03/2003
3Aftercare (After-Treatment)
07/2016 - 01/2016
2Surgical Instruments (Clip)
05/2005 - 10/2004
1Immunotherapy
07/2021